Literature DB >> 8870662

Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.

F Authier1, P H Cameron, V Taupin.   

Abstract

We have investigated the biosynthesis, subcellular location and expression of insulin-degrading enzyme (IDE). a type-I peroxisomal protease, in semi-permeabilized hepatoma cells using pulse-chase experiments, non-denaturing immunoprecipitation protocols and Northern-blot analyses. In HcpG2 cell lysates prepared from cells radiolabelled with Tran[35S]-label, immunoprecipitated IDE was observed immediately after a 5 min pulse and subsequently declined during chase with t1/2 of approx. 33 h. In addition to the 110 kDa IDE protein, a protein of 70 kDa (p70) was identified in radiolabelled immunoprecipitates when using a monoclonal anti-IDE antibody 9B12 under non-denaturing conditions. This same antibody did not recognize p70 on Western blots of whole-cell lysates nor in sequential immunoprecipitates of immunocomplex-bead eluates from anti-IDE immunoprecipitations. Likewise, cross-linking studies performed on intact HepG2 and H35 hepatoma cells in vivo revealed the existence of a hetero-oligomeric complex of 180 kDa in which IDE and p70 were physically associated. Digitonin-permeabilization studies in normal and 35S-labelled HepG2 cells have defined a predominant association of IDE and its associated protein p70 with cytosol (supernatant); only a minor amount of the protein IDE was detected in peroxisomes (cellular pellet). Immunoprecipitation of IDE from 35S-labelled cell lysates of normal and stably transfected Chinese hamster ovary cells overexpressing IDE failed to detect p70. Treatment of HepG2 cells with clofibrate, a peroxisome proliferator, resulted in a dose-dependent increase of the two human IDE transcripts of 3.6 and 3.2 kb. This effect was not accompanied by a similar change at the protein level, nor by a change in the subcellular location of the proteins IDE and p70. Based on these findings we propose that in hepatoma cells: (1) IDE mainly exists in a stable cytoplasmic pool that is unchanged in cells undergoing peroxisomal proliferation; and (2) p70 binding to IDE may serve to maintain the dual cytosolic and peroxisomal pools of IDE in a stable equilibrium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870662      PMCID: PMC1217748          DOI: 10.1042/bj3190149

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.

Authors:  F Authier; M Janicot; F Lederer; B Desbuquois
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

3.  Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III.

Authors:  J A Affholter; V A Fried; R A Roth
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

4.  Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.

Authors:  J A Affholter; C L Hsieh; U Francke; R A Roth
Journal:  Mol Endocrinol       Date:  1990-08

5.  Induction of peroxisomal beta-oxidation genes by retinoic acid in cultured rat hepatocytes.

Authors:  R Hertz; J Bar-Tana
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

6.  Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase.

Authors:  B Zhang; S L Marcus; F G Sajjadi; K Alvares; J K Reddy; S Subramani; R A Rachubinski; J P Capone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Degradation of glucagon in isolated liver endosomes. ATP-dependence and partial characterization of degradation products.

Authors:  F Authier; B Desbuquois
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

8.  Partial disassembly of peroxisomes.

Authors:  S E Alexson; Y Fujiki; H Shio; P B Lazarow
Journal:  J Cell Biol       Date:  1985-07       Impact factor: 10.539

9.  Selective degradation of insulin within rat liver endosomes.

Authors:  J J Doherty; D G Kay; W H Lai; B I Posner; J J Bergeron
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

10.  Acyl-Coa oxidase and hydratase-dehydrogenase, two enzymes of the peroxisomal beta-oxidation system, are synthesized on free polysomes of clofibrate-treated rat liver.

Authors:  R A Rachubinski; Y Fujiki; R M Mortensen; P B Lazarow
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  10 in total

1.  Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.

Authors:  V Chesneau; K Vekrellis; M R Rosner; D J Selkoe
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.

Authors:  K Vekrellis; Z Ye; W Q Qiu; D Walsh; D Hartley; V Chesneau; M R Rosner; D J Selkoe
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.

Authors:  F Authier; G M Di Guglielmo; G M Danielsen; J J Bergeron
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans.

Authors:  Andin Fosam; Shanaz Sikder; Brent S Abel; Sri Harsha Tella; Mary F Walter; Andrea Mari; Ranganath Muniyappa
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Endosomal proteolysis of internalised [ArgA0]-human insulin at neutral pH generates the mature insulin peptide in rat liver in vivo.

Authors:  M Kouach; B Desbuquois; F Authier
Journal:  Diabetologia       Date:  2009-10-16       Impact factor: 10.122

6.  Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.

Authors:  Gregor Weirich; Karin Mengele; Christina Yfanti; Apostolos Gkazepis; Daniela Hellmann; Anita Welk; Cecylia Giersig; Wen-Liang Kuo; Marsha Rich Rosner; Wei-Jen Tang; Manfred Schmitt
Journal:  Biol Chem       Date:  2008-11       Impact factor: 3.915

Review 7.  Mechanisms of Abeta clearance and catabolism.

Authors:  Suzanne Y Guénette
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

8.  Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease.

Authors:  Ayelén Bulloj; María C Leal; Huaxi Xu; Eduardo M Castaño; Laura Morelli
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Structure, function, and regulation of insulin-degrading enzyme.

Authors:  Raymond E Hulse; Luis A Ralat; Tang Wei-Jen
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

10.  Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Abeta and insulin degradation.

Authors:  Ayelén Bulloj; María C Leal; Ezequiel I Surace; Xue Zhang; Huaxi Xu; Maria D Ledesma; Eduardo M Castaño; Laura Morelli
Journal:  Mol Neurodegener       Date:  2008-12-31       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.